Drug Shortage Report for BREVIBLOC PREMIXED INJECTION

Last updated on 2019-09-17 History
Report ID 91707
Drug Identification Number 02309238
Brand name BREVIBLOC PREMIXED INJECTION
Common or Proper name BREVIBLOC PREMIXED INJECTION
Company Name BAXTER CORPORATION
Active Ingredient(s) ESMOLOL HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 250 mL Intravia Container
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-08-16
Actual start date 2019-08-16
Estimated end date 2019-09-16
Actual end date 2019-09-16
Shortage status Resolved
Updated date 2019-09-17
Company comments Very limited stock. Product on allocation. We have Brevibloc 10mg/mL VIALS available which can be reconstituted as per the customer requirement. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative.
Health Canada comments
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-09-17 English Compare
v9 2019-09-16 French Compare
v8 2019-09-16 English Compare
v7 2019-09-12 French Compare
v6 2019-09-12 English Compare
v5 2019-08-28 French Compare
v4 2019-08-28 English Compare
v3 2019-08-17 English Compare
v2 2019-08-16 French Compare
v1 2019-08-16 English Compare